History of viral hepatitis;Histórico das hepatites virais

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 3, 2010, Pages 322-330

  da Fonseca, José Carlos Ferraz ^a  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

Discoverers; History; Viral hepatitis

Indexed keywords

SMALLPOX VACCINE; YELLOW FEVER VACCINE;

DISEASE ASSOCIATION; EPIDEMIC; EYE JAUNDICE; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; HUMAN; JAUNDICE; MEDICAL INFORMATION; NONHUMAN; PANDEMIC; REVIEW; VIRUS HEPATITIS; VIRUS IDENTIFICATION; WAR;

HEPATITIS B VIRUS; VARIOLA VIRUS;

EID: 77954786570     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000300022     Document Type: Review

References (67)

1. Freitas J. Hepatites Víricas: Perspectiva histórica. Acessado no site http://www.aidsportugal.com/hepatitte, em 10 de marco de 2009 as 22:33h.
2. Reuben A. Landmarks in hepatology: the thin red line. Hepatol 2002; 36:770-773.
3. Hollinger FB. The five viruses: a perspective. AASLD Postgraduate Course "Viral hepatitis A to F: An Update; 1994. p 2-20.
4. La Condaimine MM. Journal du voyage fait par ordre du roi, a l'Equateur, servant d'introduction historique a la Mesure des trois premiers degres du meridien, 1751 (2). Acessado no site do "Center de Recherche de sur la Littérature des Voyages, Paris- França (http://www.crvl.org) em 19 de março de 2009 às 5:23h.
5. Alter HJ. The unexpected outcomes of medical research: serendipity and the Australia antigen. J Hepatol 2003; 39: 149-152.
6. Schimid R. Viral hepatitis: Some Historical Perspectives. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral Hepatitis and Liver Disease. 1994. p.1-7.
7. Franco O. História da Febre Amarela no Brasil. Ministério da Saúde-Departamento Nacional de Endemias Rurais; 1969.
8. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. New England J Med 1987; 316: 965-970.
9. Blumberg BS, Alter HJ, Visnich A. A "new" antingen in leukemia sera. JAMA 1965; 191: 541-546.
10. Blumberg BS, Gerystley BJS, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann Int Med 1967; 66: 924-931.
11. Krugman S, Giles JP, Hammond J. Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967; 200:365-373.
12. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of virus like antigen associated with acute illness. Science 1973; 182: 1026-1028.
13. Gravelle CR, Hornbeck CL, Maynard JE, Schable CA, Cook EH, Bradley DW. Hepatitis A: report of a common-source outbreak with recovery of a possible etiologic agent. II. Laboratory studies. J Inf Dis 1975; 131: 167-171.
14. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of a new antigen/antibody system (Delta/anti-Delta) associated with hepatitis B virus in liver and serum of HBsAg carriers. GUT 1977; 18: 997-1003.
15. Rizzetto M. Hepatitis Delta: The virus and disease. J Hepatol 1990; 11: 145-148.
16. Choo QL, Kuo G, Weiner A, Wang KS, Overby L, Bradley D, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
17. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmited non-A, non-B hepatitis. Science 1990; 247: 1335-1339.
18. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1:564-569.
19. Linnen J, Wages Jr J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease associated with hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-508.
20. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transminase levels in posttransfusion hepatitis of unknown etiology. Bioch Biophys Res Com 1997; 241: 92-97.
21. Tanaka Y, Primi D, Wang RY, Umemura T, Yeo AE, Mizokami M, et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and relationship to TTV family. J Inf Dis 2001, 183: 359-367.
22. Yeh CH, Chen TC, Chang ML, Hsu CW, Yeh TS, Lee WC, et al. Identification of NV-F virus in hepatocellular carcinoma. J Med Virol 2002; 79: 92-96.
23. Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, et al. Quantitation of hepatitis G and C viruses in the liver: Evidence that hepatitis G is not hepatotropic. Hepatology 1998; 27: 877-880.
24. Yeh CT, Tsao ML, Lin YC, Tseng IC. Identification of a novel single-stranded with human hepatitis. J Inf Dis 2006; 193:1089-1097.
25. Blumberg BS. Hepatitis B: The hunt for a killer virus. Princeton University Press, New Jersey; 2003.
26. Alter HJ, Blumberg BS. Further studies on a "new" human isoprecipitin system (Australia Antigen). Blood 1966; 27: 297-309.
27. Blumberg BS, Gerystley BJS, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann Int Med 1967; 66:924-931.
28. Prince AM. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Nat Acad Sci 1968; 60:814-819.
29. Dane DS, Cameron CH, Briggs M. Virus-like particules in serum of patients with Australia antigen-associated hepatitis. Lancet 1970; 1:695-698.
30. Almeida JD, Rubenstein D, Stott EJ. New antigen-antibody system in Australia-antigen positive hepatitis. Lancet 1971; 2:1224-1227.
31. Magnius LO, Espmark JA. A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand 1972; 80: 335-337.
32. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg versus anti-HBe positive carriers of hepatitis B virus. Hepatol 1983; 3: 656-662.
33. Salzano FM, Blumberg BS. The Australia antigen in Brazilian healthy persons and in leprosy and leukemia patients. J Clin Pathol 1970; 23: 39-42.
34. Bensabath G, Boshell J. Presence of Australian (Au) antigen in population groups of the interior of the State of Amazonas, Brazil. Rev Inst Med Trop São Paulo 1973; 15: 284-288.
35. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90: 1268-1273.
36. Brunetto MR, Stemler M, Bonino F, Schodel F, Oliveri F, Rizzetto M, et al. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 1990; 10:258-261.
37. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 1: 588-590.
38. Krugman S. Experiments at the Willowbrook State School. Lancet 1971; 1:966-967.
39. Blumberg BS. The Curiosities of Hepatitis B Virus, Prevention, Sex Ratio, and Demography. Proc Am Thor Soc 2006; 3: 14-20.
40. Fonseca JCF. Eradication of Hepatitis B vírus infection in the State of Amazonas. Newsletter of World Gastroenterology Organization; 2007. p.1-2.
41. Krugman S, Friedman H, Lattimer C. Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests. New Engl J Med 1975; 292:1141-1143.
42. Ticehurst JR, Racaniello VR, Baroudy BM, Baltimore D, Purcell RH, Feinstone SM. Molecular cloning and characteristization of hepatitis A virus cDNA. Proc Nat Acad Sci 1983; 60:5885-5889.
43. Fonseca JCF, Souza RAB, Brasil LM, Araújo JR, Ferreira LCL. Hepatite Fulminante na Amazônia Brasileira. Rev Soc Bras Med Trop 2004; 37 (supl II): 93-95.
44. Bensabath G, Dias LB. Hepatite de Lábrea (Febre Negra de Lábrea) e outras hepatites fulminantes em Sena Madureira, Acre e Boca do Acre, Amazonas, Brasil. Rev Inst Med Trop São Paulo 1983; 25: 182-194.
45. Fonseca JCF, Ferreira LCL, Guerra ALSP, Passos LM, Simonetti JP. Hepatite Fulminante e Febre Negra de Lábrea: Estudo de 5 casos procedentes de Codajás, Amazonas, Brasil. Rev Soc Bras Med Trop 1983;16: 144-147.
46. Fonseca JCF, Simonetti SRR, Schatzmayr HG, Castejón MJ, Cesário ALO, Simonetti JP. Prevalence of infection with hepatitis delta virus (HDV) among carriers of hepatitis B surface antigen in Amazonas State, Brazil. Trans Royal Soc Trop Med Hyg 1988; 82: 469-471.
47. Fonseca JCF, Gayotto LCC, Ferreira LCL, Araújo JR, Alecrim WD, Santos RTM, et al. Labrea hepatitis-hepatitis B and Delta antigen expression in liver tissue: report of three autopsy cases. Rev Inst Med Trop São Paulo 1985; 27:224-227.
48. Fonseca JCF, Souza RAB, Brasil LM, Araújo JR, Ferreira LCL. Fulminant hepatic failure in children and adolescents in Northern Brazil. Rev Soc Bras Med Trop 2004; 37: 67-69.
49. Rizzetto M. Hepatitis D: the comeback? Liver Intern 2009; 29:140-142.
50. Rizzetto M. Hepatitis D: Thirty years after. J Hepatol 2009; 50: 1043-1050.
51. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. New Engl J Med 1975; 292: 767-770.
52. Knodell RG, Conrad ME, Dienstag JL, Bell CJ. Etiological spectrum of post-transfusion hepatitis. Gastroenterol 1975; 69: 1278-1285.
53. Hoofnagle JH, Gerety RJ, Tabor E, Feinstone SM, Barker LF, Purcell RH. Transmission of non-A, non-B hepatitis. Ann Int Med 1977; 87:14-20.
54. Dienstag JL, Purcell HR, Alter HJ, Feinstone SM, Wong DC, Holland PV. Non-A, non-B post-transfusion hepatitis. Lancet 1977; 1: 560-562.
55. Tabor E, Mitchell FD, Goudeau AM, Gerety RJ. Detection of an antigen-antibody system in serum associated with human non-A, non-B hepatitis. J Med Virol 1979; 4: 161-169.
56. Berman M, Alter HJ, Ishak KG, Purcell RH, Jones EA. The chronic sequelae of non-A, non-B hepatitis. Ann Int Med 1979; 91:1-6.
57. Tabor E, Gerety RJ. Inactivation of an agent of human non-A, non-B hepatitis by formalin. J Inf Dis 1980; 142:767-770.
58. Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE. Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterol 1985; 88:773-779.
59. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis Nature Med 1995; 1:564-569.
60. Houghton M. Discovery of the hepatitis C. Liver Intern 2009; 29 (supl I): 82-88.
61. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
62. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 30: 1494-1500.
63. Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294-297.
64. Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, et al. Structure, sequence, and expression of the hepatitis delta viral genome. Nature 1986; 323: 508-514.
65. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008; 80: 646-658.
66. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23-31.
67. Aggarwal R. Hepatitis E: does it cause chronic hepatitis? Hepatol 2008; 48:1328-1330.